Charles Explorer logo
🇬🇧

Use of a continuous glucose monitoring in a treatment of newborn hypoglycaemia

Publication at Second Faculty of Medicine |
2018

Abstract

Hypoglycaemia is present in up to 50% newborns at risk. If hypoglycaemia is present, routine screening and following checkups are intermittently performed with bed-side glucometer or by biochemistry laboratory tests.

The use of a continuous glucose monitoring (CGM) in an interstitial tissue is more comfortable both for mother and child and it enables more detailed and less invasive monitoring of the process of glucose homeostasis. We present the case report of two siblings born to mother with the type 1 diabetes mellitus within two years.

The compensation of diabetes was almost identical both before conception and during pregnancy. Both children had CGM inserted after delivery.

The first child had severe recurrent hypoglycaemic episodes requiring hospitalization in ICU and a very high glucose supply. The second child hadn't any complications at all.